Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Psychotic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Not applicableStudy completedNCT00963924
What this trial is testing

D-cycloserine Augmentation of Cognitive Remediation in Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital 54
Early research (Phase 1)Study completedNCT04210713
What this trial is testing

Neuroimmune Dysfunction in Alcohol Use Disorder

Who this might be right for
Alcohol DrinkingAlcohol-Related DisordersDisease+13 more
University of Maryland, Baltimore 142
Post-approval studies (Phase 4)Ended earlyNCT02343575
What this trial is testing

Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU

Who this might be right for
Hyperactive DeliriumMixed Delirium
Stanford University 3
Testing effectiveness (Phase 2)Study completedNCT02624167
What this trial is testing

Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia

Who this might be right for
Chronic Schizophrenia
Newron Pharmaceuticals SPA 90
Testing effectiveness (Phase 2)Looking for participantsNCT04917302
What this trial is testing

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia

Who this might be right for
Schizophrenia
China Medical University Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT05240976
What this trial is testing

Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia

Who this might be right for
Schizophrenia
China Medical University Hospital 80
Early research (Phase 1)UnknownNCT02533232
What this trial is testing

Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Pakistan Institute of Living and Learning 60
Early research (Phase 1)Study completedNCT02074319
What this trial is testing

RCT of Methotrexate Added to Treatment As Usual in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Pakistan Institute of Living and Learning 92
Testing effectiveness (Phase 2)WithdrawnNCT01272752
What this trial is testing

Anti-psychotic Medication (New Use) Weight Loss Study

Who this might be right for
Obesity
Avera McKennan Hospital & University Health Center
Testing effectiveness (Phase 2)Study completedNCT02634684
What this trial is testing

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Who this might be right for
Schizophrenia
University of California, San Diego 82